GeoVax Labs (GOVX) Research & Development (2010 - 2026)
GeoVax Labs' Research & Development came in at $3.11 million for Q2 2026, down 34.2% from $4.73 million a year earlier.
Powered by 
Analysis
GeoVax Labs (GOVX) Research & Development (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, GeoVax Labs reported Research & Development of $15.88 million, down 36.7% year-over-year; for FY2025, it came in at $18.12 million, down 23.6% from FY2024.
- Research & Development carries a five-year compound annual growth rate of 49.3% (FY2020 to FY2025).
- Going back by year, Research & Development was $23.71 million in FY2024 (+14.4%), $20.72 million in FY2023 (+127.1%), $9.12 million in FY2022 (-41.3%) and $15.55 million in FY2021 (+536.3%).
- The five-year range for quarterly Research & Development is $1.22 million (Q3 2021) to $12.89 million (Q4 2021).
- Year-over-year, Research & Development increased in four of the last seven quarters, with an average decline of 9.5%.
- The fastest year-over-year change in Research & Development over five years came in Q2 2023 (growth of 261.1%), and the weakest in Q4 2022 (a decline of 70.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | GeoVax Labs | 1.60 Mn | -12.73 Mn | - | 3.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.11 Mn |
| Dec 31, 2025 | 2.99 Mn |
| Sep 30, 2025 | 5.04 Mn |
| Jun 30, 2025 | 4.73 Mn |
| Mar 31, 2025 | 5.35 Mn |
| Dec 31, 2024 | 7.61 Mn |
| Sep 30, 2024 | 7.40 Mn |
| Jun 30, 2024 | 4.28 Mn |
| Mar 31, 2024 | 4.43 Mn |
| Dec 31, 2023 | 6.23 Mn |
| Sep 30, 2023 | 6.95 Mn |
| Jun 30, 2023 | 4.72 Mn |
| Mar 31, 2023 | 2.82 Mn |
| Dec 31, 2022 | 3.76 Mn |
| Sep 30, 2022 | 2.72 Mn |
| Jun 30, 2022 | 1.31 Mn |
| Mar 31, 2022 | 1.33 Mn |
| Dec 31, 2021 | 12.89 Mn |
| Sep 30, 2021 | 1.22 Mn |
| Jun 30, 2021 | 832,835.00 |
API Access
GeoVax Labs Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=GOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "GOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=GOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();